1.
Study and Improvement on Mechanism of Administrative ADR;
我国行政性ADR的理论研究和制度完善
2.
The value defining and the practice of the administrative ADR in China;
我国行政性ADR之价值界定与实践
3.
The Study on the Our Country's Administrative ADR Scheme of the Environmental Pollution Dispute;
我国环境污染纠纷行政性ADR机制构建研究
4.
On Demonstration of ADR s Constitutionality for Administrative Dispute Resolution;
ADR适用于解决行政纠纷的合宪性论证
5.
The New Development of ADR in Hong Kong SAR--In the View of Mandatory Mediation in Commercial Disputes;
香港特别行政区ADR发展的新动向——商事争议强制性调解机制的兴起
6.
Reflections on the settlement of our country s administrative dispute based on american ADR;
基于美国ADR对我国行政争议解决的思考
7.
On the Disputes Solution in International Government Procurement Contract by Employing ADR;
运用ADR解决国际政府采购合同纠纷
8.
Study on IPO Under-pricing Issued by China ADR;
对于中国ADR发行的IPO抑价研究
9.
An Introduction to and Evaluation of America s ADR;
美国替代性纠纷解决方式（ADR）介评
10.
The Establishment of ADR System in China;
ADR与我国代替性纠纷解决机制的建立
11.
On The Necessity of Setting up ARD in China and Its Pertinent Assumption;
在我国建构ADR机制的必要性及相关设想
12.
Establishment of an Adriamycin Resistant Human Leukemia Cell Line U937/ADR and Its Biological Characterizations
白血病耐药细胞系U937/ADR的建立及其生物学性状
13.
Reversal Effects of Low-frequency Pulsed Electrical Field on Multidrug Resistance of MCF-7/ADR to HHT and VCR;
低频脉冲电场逆转MCF-7/ADR对HHT和VCR耐药性的研究
14.
Arsenic Trioxide Reverses the Multidrug Resistance of Gastric Carcinoma Cell Line SGC7901/ADR to Adriamycin;
三氧化二砷对胃癌细胞SGC7901/ADR多药耐药性逆转作用的研究
15.
Preliminary Study to Negative-regulative Mechanism of Radiative-sensitivity by P-glycoprotein in MCF-7/ADR Cells;
P糖蛋白对MCF-7/ADR细胞辐射敏感性负调控机制的初步研究
16.
Interleukin-2 Reverse the Multidrug Resistance of Gastric Carcinoma Cell Line SGC7901/ADR to Adriamycin;
重组人白细胞介素-2对人胃癌细胞SGC7901/ADR多药耐药性的逆转研究
17.
RNAi-Mediated Gene Silencing of Breast Cancer Resistance Protein Reverse Drug-Resistance of MCF-7/ADR;
RNA干扰BCRP基因表达逆转乳腺癌耐药细胞MCF-7/ADR耐药性的实验研究
18.
Phenylpropanoid glycosides reversing effect on multidrug resistance of colon carcinoma LoVo/Adr cells
苯丙素甙化合物逆转大肠癌LoVo/Adr细胞多药耐药性